Terapio

Terapio Corporation is a biopharmaceutical company founded in 2005 and based in Austin, Texas. The company specializes in developing therapeutics that utilize the transport protein RLIP76, which plays a crucial role in moving free-radical toxins out of cells, thereby preventing significant cellular damage. Terapio's pipeline includes therapies that enhance the availability of RLIP76 in normal cells, improving their ability to combat toxins from various sources, including chemical exposure and radiation. The therapeutics are designed as medical countermeasures, providing prophylactic and post-exposure treatment options for civilian, military, and first responder populations facing chemical and radiation threats.